Detalles de la búsqueda
1.
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study.
J Neurol Neurosurg Psychiatry
; 95(2): 142-150, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37775266
2.
Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis.
Mult Scler
; 30(4-5): 600-604, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38323423
3.
Decentralised clinical trials in multiple sclerosis research.
Mult Scler
; 29(3): 317-325, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35735014
4.
Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS Register.
Mult Scler
; 28(7): 1060-1071, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34080892
5.
Lymphocyte counts and the risk of COVID-19 in people with MS.
Mult Scler
; 27(10): 1625-1626, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33064054
6.
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register.
J Neurol Neurosurg Psychiatry
; 2020 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32855290
7.
An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis.
Expert Opin Pharmacother
; 24(4): 495-509, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36946625
8.
Recovery From COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register.
Neurol Neuroimmunol Neuroinflamm
; 9(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34848503
9.
Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England.
Mult Scler Relat Disord
; 57: 103458, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34896876
10.
Challenges of developing, conducting, analysing and reporting a COVID-19 study as the COVID-19 pandemic unfolds: an online co-autoethnographic study.
BMJ Open
; 11(6): e048788, 2021 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34135052
11.
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies.
Mult Scler Relat Disord
; 52: 102939, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34010764
12.
Association between platelet count as a noninvasive marker and ultrasonographic grading in patients with nonalcoholic Fatty liver disease.
Hepat Mon
; 15(1): e24449, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25741373
13.
Hydrocortisone reduces Toll-like receptor 4 expression on peripheral CD14+ monocytes in patients undergoing percutaneous coronary intervention.
Iran Biomed J
; 18(2): 76-81, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24518547
14.
Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats.
Pharmacol Rep
; 64(6): 1476-84, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23406758
15.
Monocyte expression of Toll-like receptor-4 in patients with stable angina undergoing percutanoeus coronary intervention.
Iran J Immunol
; 9(3): 149-58, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23023379
16.
Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat.
Eur J Pharmacol
; 666(1-3): 135-41, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21570962
Resultados
1 -
16
de 16
1
Próxima >
>>